Robert F. Kennedy Jr.: How to Fix America’s Health Crisis as HHS Secretary | TUH #169

Kennedy drew on his knowledge from tobacco litigation to describe the deliberate engineering of food softeners. He said that after tobacco companies bought food giants, their scientists discovered that the brain counts chewing cycles and they set out to defeat that mechanism. Most people don’t realize that the texture of modern processed food is not an accident; it’s designed to eliminate chewing and thereby dismantle a subconscious satiety regulator. The implication is that even if you eat a calorically dense meal of soft foods, your brain may still think you’re hungry because the chewing count didn’t reach the expected threshold. Simply reintroducing foods that require serious chewing—like whole apples instead of applesauce, or nuts instead of nut butters—can help restore this primal feedback loop.

Kennedy connected this directly to the tobacco‑industry playbook. After acquiring food companies, tobacco scientists set out to hijack the brain’s reward and satiety pathways, just as they had with nicotine. They developed chemical compounds that taste enticing but provide zero nutrition, meaning the consumer keeps eating while the body keeps starving. He emphasized that the food being sold is no longer food but a ‘foodlike substance’—nutrient‑anemic and deliberately designed to never produce satiation. This explains the seeming contradiction of soaring obesity rates alongside widespread nutrient deficiencies. He positioned the solution not as willpower but as a return to foods that actually contain the nutrients the brain expects, thereby restoring the natural stop‑eating signals.

RFK Jr. argued that the lack of replication creates a massive incentive to cheat, because scientists know no one will ever attempt to reproduce their work. He pointed out that even public‑sector scientists sometimes write the conclusion before the study, mirroring the behavior of ‘biostitutes’ in industry‑funded research. By devoting 20% of NIH’s budget to reproducing every study, he intends to make cheating much harder and restore scientific integrity. He also plans to stop the revolving door of publication in commercial journals that have explicitly said they are no longer science journals. Instead, NIH will launch its own journals within each institute. He believes these will become the new gold standard because NIH funding itself anoints a scientist as legitimate, and the journals will be free of pharma’s financial influence. The announcement is a sharp break from the current system and signals a fundamental restructuring of how US biomedical science is conducted and disseminated.

Kennedy’s position is that the FDA should return to being a science‑based information provider, not a gatekeeper that limits American patients to a narrow set of industry‑approved drugs. He explicitly stated that if someone wants to take an experimental drug or pursue stem cell therapy, they ‘ought to be able to do that’ without having to leave the country. He acknowledged the risk of charlatans and bad outcomes but said those risks are inherent, and the current pharma‑only approach has already made Americans the sickest population in the developed world. He shared his own experience of having to fly to Antigua for stem cell treatment for his throat, which he said helped him enormously, and questioned why that was necessary. This speech signals a forthcoming regulatory philosophy that prioritizes personal medical freedom alongside transparent science, potentially opening the door for a wide range of currently fringe interventions.

He explained that tobacco companies foresaw the decline of cigarette sales and used their enormous cash reserves to diversify into food, purchasing thousands of scientists whose expertise was in making substances more addictive. They systematically developed chemicals that mimic appealing flavors (e.g., strawberry) without any actual nutrients, so the body never releases GLP‑1 and never registers satiety. They also introduced food softeners to reduce the need to chew, knowing that the brain tracks chewing cycles as a proxy for stomach fullness. The result is a food environment where people overconsume calories while their bodies still cry out for nutrients, leading to the paradox of obesity with malnutrition. This narrative challenges the mainstream framing that blames individual willpower and instead attributes the crisis to deliberate corporate engineering.

RFK Jr. said that the Sacklers ‘captured an FDA official and persuaded him to eliminate the warnings about the addiction’ and to state on the package insert that oxycodone was not addictive. He argued that you can draw a straight line from that action to the over‑100,000 young Americans dying each year from drug overdoses, a number he contrasts with the 56,000 lost in the entire Vietnam War. He noted that lower‑level division chiefs see this behavior modeled from the top and emulate it, expecting future employment in industry once their government pensions vest. This specific example served to illustrate the larger structural problem he intends to dismantle: the revolving door between FDA/CDC and the companies they regulate, which he says has transformed health agencies into ‘sock puppets’ of industry.

Kennedy argued that pharma advertising spending on evening news is a form of control—much like defense contractors advertising on Good Morning America even though no viewer is buying a Tomahawk missile. The companies want to shape content, and anchors know their paychecks ultimately come from those ad dollars. He noted that 20 years ago, programs like 60 Minutes and even CNN’s Sanjay Gupta would raise questions about vaccine safety or drug side effects, but today that skepticism has evaporated. This media capture, he says, ensures a one‑sided public conversation focused on fear of infectious disease and compliance with pharmaceutical mandates, while systematically ignoring the harms of the products being marketed. He indicated that the administration is looking for ways to address direct‑to‑consumer pharmaceutical advertising, though a unfavourable Supreme Court decision complicates outright bans.